F19.139
Other psychoactive substance abuse with withdrawal, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F19.139 pertains to a condition involving the abuse of psychoactive substances, accompanied by withdrawal symptoms. This classification captures cases where the specific substance used isn't detailed, but the overall pattern indicates problematic use leading to physical and psychological withdrawal when not using the substance. Psychoactive substances include drugs like alcohol, opioids, stimulants, sedatives, and hallucinogens that affect the mind and behavior. Recognizing this condition is essential for providing appropriate care and support to individuals facing substance abuse and dependence issues.
Causes & Symptoms
Clinical Causes: Repeated and prolonged use of psychoactive substances, leading to physical dependence Genetic predisposition to substance addiction Psychological factors such as stress, trauma, or mental health disorders Environmental influences including peer pressure, availability of substances, or stressful life circumstances Lack of awareness or access to treatment for substance abuse issues
Key Symptoms: Craving or strong desire to use the substance Inability to control or reduce substance intake Physical withdrawal symptoms when not using the substance, such as sweating, trembling, nausea, or headaches Psychological symptoms like anxiety, irritability, depression, or insomnia Social withdrawal or neglect of responsibilities Engaging in risky behaviors to obtain or use the substance
Diagnostic & Treatment
Diagnosis Path: Diagnosis of this condition typically involves a clinical assessment by a healthcare professional, including a detailed patient history and physical examination. Diagnostic criteria from established manuals, such as the DSM-5 or ICD-10, are used to identify substance use disorder and withdrawal symptoms. Laboratory tests, such as blood or urine screenings, may assist in confirming recent substance use. The healthcare provider evaluates the severity of dependence, presence of withdrawal symptoms, and the impact on the individual’s daily functioning to determine the appropriate diagnosis.
Treatment Protocols: Detoxification programs supervised by medical professionals to safely manage withdrawal symptoms Psychotherapy, including cognitive-behavioral therapy (CBT), to address behavioral patterns and underlying issues Pharmacological interventions to reduce cravings or mitigate withdrawal effects, depending on the specific substance involved Supportive care such as peer support groups, family therapy, and educational programs Relapse prevention strategies and ongoing monitoring to maintain sobriety
Clinical Advice & FAQs
Billing Guidance
Is F19.139 a billable ICD-10 code?
Yes, F19.139 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F19.139?
Clinical documentation must specify the nature of Other psychoactive substance abuse with withdrawal, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
